Literature DB >> 66572

Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.

S Franks, J D Nabarro.   

Abstract

Serum-prolactin concentrations were measured in 111 patients who had radiological abnormalities of the pituitary but no evidence of acromegaly, Cushing's syndrome, or Nelson's syndrome. Raised prolactin levels were found in 45 of 64 (70%) patients studied before treatment and in 15 of 47 patients studied after pituitary surgery. The majority of hyperprolactinaemic patients presented with amenorrhoea or impotence; galactorrhoea was uncommon. By contrast, reproductive disorders were rare in patients with normal prolactin levels. It is concluded that pituitary tumours previously described as "functionless" are frequently associated with hypersecretion of prolactin and that such tumours usually present as reproductive disorders. In the investigation of patients with amenorrhoea or impotence serum-prolactin should be measured and skull radiology performed if the prolactin level is raised. Prolactin should be measured in all patients with abnormal pituitary X-rays both before and after pituitary surgery.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66572     DOI: 10.1016/s0140-6736(77)92959-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

Review 1.  Prolactin: role in health and disease.

Authors:  D F Horrobin
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 2.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Prolactinoma.

Authors:  M O Thorner
Journal:  West J Med       Date:  1983-11

4.  The management of prolactin-secreting pituitary tumors.

Authors:  S R George; G N Burrow
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

5.  Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. II. Psychosocial situation and pituitary function.

Authors:  M Sääf; M Thorén; C G Bergstrand; G Norén; T Rähn; L Tallstedt; E O Backlund
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

6.  Prevalence and incidence of pituitary adenomas: a population based study in Malta.

Authors:  Mark Gruppetta; Cecilia Mercieca; Josanne Vassallo
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

7.  Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment.

Authors:  O Serri; M Somma; E Rasio; H Beauregard; J Hardy
Journal:  Can Med Assoc J       Date:  1980-05-10       Impact factor: 8.262

Review 8.  Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Authors:  S Franks
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

9.  Treatment of patients with prolactinomas.

Authors:  K v Werder; R Fahlbusch; R Landgraf; C R Pickardt; H K Rjosk; P C Scriba
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

Review 10.  [Human prolactin (author's transl)].

Authors:  K von Werder; H K Rjosk
Journal:  Klin Wochenschr       Date:  1979-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.